Literature DB >> 25546798

Optimizing immunoglobulin G therapy in chronic autoimmune neuropathies.

M Berger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546798      PMCID： PMC4285527          DOI： 10.1111/cei.12547

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision.

Authors: 
Journal:  J Peripher Nerv Syst       Date:  2010-03       Impact factor: 3.494

2.  Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy.

Authors:  Yusuf A Rajabally; Hanny Seow; Patrick Wilson
Journal:  J Peripher Nerv Syst       Date:  2006-12       Impact factor: 3.494

3.  Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  L H Markvardsen; J-C Debost; T Harbo; S H Sindrup; H Andersen; I Christiansen; M Otto; N K Olsen; L L Lassen; J Jakobsen
Journal:  Eur J Neurol       Date:  2013-01-07       Impact factor: 6.089

4.  Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy.

Authors:  L H Markvardsen; T Harbo; S H Sindrup; I Christiansen; H Andersen; J Jakobsen
Journal:  Eur J Neurol       Date:  2014-07-07       Impact factor: 6.089

5.  Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.

Authors:  Patrizia Dacci; Nilo Riva; Marina Scarlato; Irmgard Andresen; Dirksteffen Schmidt; Giancarlo Comi; Raffaella Fazio
Journal:  Neurol Sci       Date:  2010-06-24       Impact factor: 3.307

6.  Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.

Authors:  Thomas Harbo; Henning Andersen; Johannes Jakobsen
Journal:  Neurology       Date:  2010-10-12       Impact factor: 9.910

Review 7.  CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.

Authors:  John D Pollard; Patricia J Armati
Journal:  J Peripher Nerv Syst       Date:  2011-03       Impact factor: 3.494

8.  Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn; Marinus Vermeulen; Leonard H van den Berg; Esther Brusse; Anneke J van der Kooi; W-Ludo van der Pol; Ivo N van Schaik; Nicolette Notermans; Anne P Tio-Gillen; Wouter van Rijs; Teun van Gelder; Bart C Jacobs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-28       Impact factor: 10.154

9.  Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.

Authors:  Randy Broyles; Linda Rodden; Patty Riley; Melvin Berger
Journal:  Postgrad Med       Date:  2013-03       Impact factor: 3.840

Review 10.  Node of Ranvier disruption as a cause of neurological diseases.

Authors:  Keiichiro Susuki
Journal:  ASN Neuro       Date:  2013-08-07       Impact factor: 4.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.